Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fabino Life Sciences Ltd - 543444 - Authorisation Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015

 Pursuant to requirement under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the contact details of the Key Managerial Personnel ('KMP') who have being authorized by Board of Directors of the Company, for the purpose of determining materiality of an event or information, is enclosed with this letter.
02-05-2023
Bigul

Fabino Life Sciences Ltd - 543444 - Appointment of Company Secretary and Compliance Officer

 Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that, Board has appointed in its meeting held today CS Kanchi Gehlot as Company Secretary and Compliance Officer w.e.f May 02, 2023 in replacement of CS Aslam Mohammed. The disclosure pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015 is enclosed as Annexure A.
02-05-2023
Bigul

Fabino Life Sciences Ltd - 543444 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 02Nd May, 2023

 The Board of Directors of the Company at their meeting held today i.e. 02nd May, 2023 has inter alia, considered and approved the following: 1. Acceptance of Resignation of CS Aslam Mohammed as Company Secretary and Compliance Officer of the Company. 2. Appointment of CS Kanchi Gehlot as Company Secretary and Compliance Officer of the Company w.e.f. May 02, 2023. The disclosure pursuant to point 2 of Regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015 is enclosed as Annexure A. The meeting of Board of Directors commenced at 4.30 P.M and concluded at 05:00 P.M.
02-05-2023
Bigul

Fabino Life Sciences Ltd - 543444 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

 Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that, CS Aslam Mohammad has resigned from the Company as Company Secretary and Compliance Officer from April 25, 2023 (after closure of business hours), and the same will be placed by the Board in the ensuing Board Meeting. The Company appreciates the valuable services rendered by CS Aslam Mohammad, during his tenure as Company Secretary and Compliance Officer of the Company.
25-04-2023
Bigul

Fabino Life Sciences Ltd - 543444 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyFabino Life Sciences Ltd 2CIN NO.U24100DL2011PLC226781 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.41 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: ASLAM MOHAMMAD Designation: COMPANY SECRETARY EmailId: info@fabinolife.com Name of the Chief Financial Officer: PANKAJ JAIN Designation: CHIEF FINANCIAL OFFICER EmailId: info@fabinolife.com Date: 18/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
18-04-2023
Bigul

Fabino Life Sciences Ltd - 543444 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 With reference to the above captioned subject, we Fabino Life Sciences Limited would like to inform you that as per the Regulation 15(2) of SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 the Annual Secretarial Compliance Report under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018 is not applicable to our company as our securities are listed in SME Platform of BSE, therefore compliances as Regulation 24A is not applicable to the Company.
18-04-2023
Bigul

Fabino Life Sciences Ltd - 543444 - Certificate As Per Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Year Ended March 31, 2023.

 Please find enclosed herewith the certificate dated April 18, 2023 from JNG & Co, Practicing Company Secretaries under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the year ended March 31, 2023.
18-04-2023
Bigul

Fabino Life Sciences Ltd - 543444 - Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Year Ended March 31, 2023

 Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby certify that all activities in relation to both physical and electronic share transfer facility are maintained during the period from April 01, 2022 to March 31, 2023 (both days inclusive) by company's Share Transfer Agent i.e. Bigshare Services Private Limited having permanent SEBI Registration No: INR000001385.
18-04-2023
Bigul

Fabino Life Sciences Ltd - 543444 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find enclosed herewith the Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2023 dated April 07, 2023 received from M/s Bigshare Services Private Limited, the Registrar and Share Transfer Agent of the Company.
17-04-2023
Bigul

Fabino Life Sciences Ltd - 543444 - Closure of Trading Window

 We hereby inform you that in terms of Company's Code for prevention of Insider Trading framed under SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company would remain close from Saturday, 1st April, 2023 till the completion of 48 hours after announcement of the Audited Financial Results of year ended 31st March, 2023; for Designated persons of the Company including their immediate relatives.
29-03-2023
Next Page
Close

Let's Open Free Demat Account